Evidence map›Paper›PMID 23650571›Full record

ArticleFEBS open bio2011

Green algae Chlamydomonas reinhardtii possess endogenous sialylated N-glycans.

Tarlan Mamedov, Vidadi Yusibov

Abstract read
In one paragraph

Article in FEBS open bio, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Five years on -FEBS open bio · 2016
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tarlan MamedovFraunhofer USA Center for Molecular Biotechnology, Newark, DE, USA.
Vidadi Yusibov

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Green algae have a great potential as biofactories for the production of proteins. Chlamydomonas reinhardtii, a representative of eukaryotic microalgae, has been extensively used as a model organism to study light-induced gene expression, chloroplast biogenesis, photosynthesis, light perception, cell-cell recognition, and cell cycle control. However, little is known about the glycosylation machinery and N-linked glycan structures of green algae. In this study, we performed mass spectrometry analysis of N-linked oligosaccharides released from total extracts of Chlamydomonas reinhardtii and demonstrated that C. reinhardtii algae possess glycoproteins with mammalian-like sialylated N-linked oligosaccharides. These findings suggest that C. reinhardtii may be an attractive system for expression of target proteins.

Indexed as

2-AB, 2-aminobenzamideChlamydomonas reinhardtiiCST, CMP-sialic acid transporterER, endoplasmic reticulumhEPO, human erythropoietinHPLC-FLD, high-performance liquid chromatography using fluorescence detectionHRP, horseradish peroxidaseMALDI-TOF-MS, matrix-assisted laser desorption/ionization time of flight mass spectrometryMass spectrometry analysisMS, mass spectrometryN-Glycan structurePBS, phosphate buffered salinePVDF, polyvinylidene fluorideRCA, Ricinus communis agglutininSDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresisSialic acidTBS, Tris-buffered saline

Identifiers

PMID23650571
PMCPMC3642053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.